<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03469505</url>
  </required_header>
  <id_info>
    <org_study_id>Heapy01.26.2018</org_study_id>
    <nct_id>NCT03469505</nct_id>
  </id_info>
  <brief_title>Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)</brief_title>
  <acronym>COPES ExTRA</acronym>
  <official_title>Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To conduct a superiority trial of COPES versus standard Veterans Health Administration (VHA)
      Cognitive Behavioral Therapy Chronic Pain (CBT-CP)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our prior efficacy trial found that COPES was not inferior to in-person CBT-CP and that
      participants attended, on average, a little over two more treatment weeks in COPES than
      in-person treatment, presumably due to the ease of in-home treatment attendance relative to
      in-person treatment.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brief Pain Inventory</measure>
    <time_frame>1 month</time_frame>
    <description>The Total Brief Pain Inventory Score is a composite of patient-reported pain intensity and pain-related interference. Data will be collected through automated Interactive Voice Response (IVR) calls.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brief Pain Inventory</measure>
    <time_frame>3 months</time_frame>
    <description>The Total Brief Pain Inventory Score is a composite of patient-reported pain intensity and pain-related interference. Data will be collected through automated IVR calls.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brief Pain Inventory</measure>
    <time_frame>6 months</time_frame>
    <description>The Total Brief Pain Inventory Score is a composite of patient-reported pain intensity and pain-related interference. Data will be collected through automated IVR calls.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brief Pain Inventory</measure>
    <time_frame>12 months</time_frame>
    <description>The Total Brief Pain Inventory Score is a composite of patient-reported pain intensity and pain-related interference. Data will be collected through automated IVR calls.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Current Pain Intensity Rating</measure>
    <time_frame>1 month</time_frame>
    <description>VHA care guidelines specify that the 11-point (no pain) to (worst pain imaginable) Numeric Rating Scale (NRS) for current pain be collected at the point of care for every visit as part of the vital signs assessment. This data will be extracted from the electronic health records (EHR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current Pain Intensity Rating</measure>
    <time_frame>3 months</time_frame>
    <description>VHA care guidelines specify that the 11-point (no pain) to (worst pain imaginable) NRS for current pain be collected at the point of care for every visit as part of the vital signs assessment.This data will be extracted from the electronic health records (EHR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current Pain Intensity Rating</measure>
    <time_frame>6 months</time_frame>
    <description>VHA care guidelines specify that the 11-point (no pain) to (worst pain imaginable) NRS for current pain be collected at the point of care for every visit as part of the vital signs assessment.This data will be extracted from the electronic health records (EHR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current Pain Intensity Rating</measure>
    <time_frame>12 months</time_frame>
    <description>VHA care guidelines specify that the 11-point (no pain) to (worst pain imaginable) NRS for current pain be collected at the point of care for every visit as part of the vital signs assessment.This data will be extracted from the electronic health records (EHR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Perception of Change</measure>
    <time_frame>1 month</time_frame>
    <description>The Patient Global Perception of Change scale is a single item measure that quantifies a participant's overall perception of improvement since beginning treatment and the clinical importance of that improvement. Participants indicate improvement on a 7 point &quot;much worse&quot; to &quot;much better&quot; scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Perception of Change</measure>
    <time_frame>3 months</time_frame>
    <description>The Patient Global Perception of Change scale is a single item measure that quantifies a participant's overall perception of improvement since beginning treatment and the clinical importance of that improvement. Participants indicate improvement on a 7 point &quot;much worse&quot; to &quot;much better&quot; scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Perception of Change</measure>
    <time_frame>6 months</time_frame>
    <description>The Patient Global Perception of Change scale is a single item measure that quantifies a participant's overall perception of improvement since beginning treatment and the clinical importance of that improvement. Participants indicate improvement on a 7 point &quot;much worse&quot; to &quot;much better&quot; scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Perception of Change</measure>
    <time_frame>12 months</time_frame>
    <description>The Patient Global Perception of Change scale is a single item measure that quantifies a participant's overall perception of improvement since beginning treatment and the clinical importance of that improvement. Participants indicate improvement on a 7 point &quot;much worse&quot; to &quot;much better&quot; scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression symptom severity</measure>
    <time_frame>1 month</time_frame>
    <description>Depression symptom severity will be assessed using the 9-item Patient Health Questionnaire (PHQ-9) a widely-used measure with excellent internal consistency and stability. Data will be collected through an automated IVR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression symptom severity</measure>
    <time_frame>3 months</time_frame>
    <description>Depression symptom severity will be assessed using the 9-item Patient Health Questionnaire (PHQ-9) a widely-used measure with excellent internal consistency and stability. Data will be collected through an automated IVR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression symptom severity</measure>
    <time_frame>6 months</time_frame>
    <description>Depression symptom severity will be assessed using the 9-item Patient Health Questionnaire (PHQ-9) a widely-used measure with excellent internal consistency and stability. Data will be collected through an automated IVR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression symptom severity</measure>
    <time_frame>12 months</time_frame>
    <description>Depression symptom severity will be assessed using the 9-item Patient Health Questionnaire (PHQ-9) a widely-used measure with excellent internal consistency and stability. Data will be collected through an automated IVR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing Scale</measure>
    <time_frame>1 month</time_frame>
    <description>The Pain Catastrophizing Scale (PCS) a 13-item self-report scale that examines thoughts and feelings people may experience when they are in pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing Scale</measure>
    <time_frame>3 months</time_frame>
    <description>The Pain Catastrophizing Scale (PCS) a 13-item self-report scale that examines thoughts and feelings people may experience when they are in pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing Scale</measure>
    <time_frame>6 months</time_frame>
    <description>The Pain Catastrophizing Scale (PCS) a 13-item self-report scale that examines thoughts and feelings people may experience when they are in pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing Scale</measure>
    <time_frame>12 months</time_frame>
    <description>The Pain Catastrophizing Scale (PCS) a 13-item self-report scale that examines thoughts and feelings people may experience when they are in pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>1 month</time_frame>
    <description>Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI) and will assess subjective sleep quality. Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>3 months</time_frame>
    <description>Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI) and will assess subjective sleep quality. Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>6 months</time_frame>
    <description>Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI) and will assess subjective sleep quality. Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>12 months</time_frame>
    <description>Sleep quality will be measured using the Pittsburgh Sleep Quality Index (PSQI) and will assess subjective sleep quality. Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Efficacy</measure>
    <time_frame>1 month</time_frame>
    <description>Self-Efficacy will be assessed using the 2-Item Short Form of the Pain Self-Efficacy Questionnaire (PSEQ-2). Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Efficacy</measure>
    <time_frame>3 months</time_frame>
    <description>Self-Efficacy will be assessed using the 2-Item Short Form of the Pain Self-Efficacy Questionnaire (PSEQ-2). Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Efficacy</measure>
    <time_frame>6 months</time_frame>
    <description>Self-Efficacy will be assessed using the 2-Item Short Form of the Pain Self-Efficacy Questionnaire (PSEQ-2). Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Efficacy</measure>
    <time_frame>12 months</time_frame>
    <description>Self-Efficacy will be assessed using the 2-Item Short Form of the Pain Self-Efficacy Questionnaire (PSEQ-2). Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-Related Quality of Life</measure>
    <time_frame>1 month</time_frame>
    <description>We will use the Veterans SF-12 to assess health-related quality of life. Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-Related Quality of Life</measure>
    <time_frame>3 months</time_frame>
    <description>We will use the Veterans SF-12 to assess health-related quality of life. Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-Related Quality of Life</measure>
    <time_frame>6 months</time_frame>
    <description>We will use the Veterans SF-12 to assess health-related quality of life. Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-Related Quality of Life</measure>
    <time_frame>12 months</time_frame>
    <description>We will use the Veterans SF-12 to assess health-related quality of life. Data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Outcomes</measure>
    <time_frame>1 month</time_frame>
    <description>Pain outcomes will be measured using the Patient Outcomes Questionnaire. This 5-item measure shows good internal consistency and significant associations with staff and patient ratings of patient improvement. The data will be collected through automated IVR calls.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">723</enrollment>
  <condition>Pain, Chronic</condition>
  <arm_group>
    <arm_group_label>data from veterans using COPES</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Data from veterans using COPES for chronic pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>data from veterans using CBT-CP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Data from veterans using CBT-CP for chronic pain</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>COPES</intervention_name>
    <description>Cooperative Pain Education and Self-Management for chronic pain therapy.</description>
    <arm_group_label>data from veterans using COPES</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT-CP</intervention_name>
    <description>Cognitive Behavioral Therapy for Chronic Pain</description>
    <arm_group_label>data from veterans using CBT-CP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with chronic musculoskeletal pain receiving care in VHA.

          -  A pain-related musculoskeletal diagnosis indicated by an EHR identified ICD-9 or -10
             code.

          -  The presence of chronic pain of at least moderate severity with EHR NRS pain scores â‰¥
             4 in three separate months for a period of 12 months.

          -  Absence of mental illness serious enough to have resulted in an inpatient psychiatric
             hospitalization in the prior 3 months excluding detoxification of alcohol or drugs.

          -  Absence of malignant cancer diagnosis or receipt of hospice or end-of-life palliative
             care.

          -  Ability to participate safely in the walking portion of the intervention as evidenced
             by patient-reported ability to walk at least one block and absence of diabetic foot
             ulcers at the time of the enrollment.

          -  Absence of significant cognitive impairment as identified by a dementia-related
             diagnosis.

          -  Availability of a touch-tone land-line or cellular telephone and no vision or hearing
             deficits that would impair participation verified by patient report at the time of the
             enrollment call.

        Exclusion Criteria:

          -  Patients not fitting criteria for inclusion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alicia Heapy, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Office of Research and Development</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathryn LaChappelle, MPH</last_name>
    <phone>203-932-5711</phone>
    <phone_ext>2812</phone_ext>
    <email>kathryn.lachappelle@va.gov</email>
  </overall_contact>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2018</study_first_submitted>
  <study_first_submitted_qc>March 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2018</study_first_posted>
  <last_update_submitted>March 15, 2018</last_update_submitted>
  <last_update_submitted_qc>March 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

